Why Eli Lilly (LLY) Stock Fell 0.87% in 10 Minutes on Nov 19, 2026
The 0.87% drop was larger than any reaction MoveSurge measured after Eli Lilly headlines between Aug 21, 2026 and Nov 18, 2026; the largest of those was +0.60% in 10 minutes, on Nov 9, 2026.
- LLY fell 0.87% in the 10 minutes after the 10:31:41 ET headline, from $1,360.48 to $1,348.60.
- The move kept building after the first minute: -0.22% at one minute, -0.87% at 10 minutes.
Reaction by asset (real prices)
| Asset | 2m before | At release | +1m | +10m | +1m % | +10m % |
|---|---|---|---|---|---|---|
| LLY | 1360.48 | 1360.48 | 1357.46 | 1348.60 | -0.22% | -0.87% |
Eli Lilly (LLY) shares fell 0.87% in the 10 minutes after this headline reached the MoveSurge news feed at 10:31:41 ET on Thursday, November 19, 2026: “Eli Lilly (LLY) options: 354 Dec 31 '26 $1355 puts traded at the midpoint for $1.98M, above open interest of 1”
LLY in the first 10 minutes
From a reference price of $1,360.48 just before the headline, the stock was down 0.22% after one minute and down 0.87%, at $1,348.60, after 10 minutes. The move kept building after the first minute.
Earlier LLY headlines and the measured reaction
The 0.87% drop was larger than any reaction MoveSurge measured after Eli Lilly headlines between Aug 21, 2026 and Nov 18, 2026; the largest of those was +0.60% in 10 minutes, on Nov 9, 2026.
- Nov 17, 2026, 10:42 ET: “Eli Lilly (LLY) options: 136 Dec 18 '26 $1200 calls traded at the bid for $3.22M” (-0.51% in 10 minutes)
- Nov 11, 2026, 10:42 ET: “Eli Lilly (LLY) options: 140 Jan 2028 $2000 calls traded at the bid for $1.28M, above open interest of 132” (-0.38% in 10 minutes)
- Nov 9, 2026, 12:10 ET: “Eli Lilly spokesperson says company is carefully evaluating FDA drug-safety communication for GLP-1 RA and will respond promptly” (+0.36% in 10 minutes)
- Nov 9, 2026, 09:40 ET: “In a late-stage trial, Eli Lilly (LLY) says Zepbound, its obesity pill, significantly eased obstructive sleep apnea severity among patients with obesity.” (+0.60% in 10 minutes)
- Nov 6, 2026, 12:49 ET: “Hims & Hers partners directly with Eli Lilly on obesity drugs” (-0.35% in 10 minutes)
- Nov 2, 2026, 14:46 ET: “Eli Lilly (LLY) options: 250 Jan 2028 $1600 calls traded at the bid for $4.63M” (+0.28% in 10 minutes)
Eli Lilly at a glance
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Market value | $1.30 trillion (as of Nov 20, 2026) |
Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.
What headline moved Eli Lilly stock on November 19, 2026?
At 10:31:41 ET, this headline crossed: “Eli Lilly (LLY) options: 354 Dec 31 '26 $1355 puts traded at the midpoint for $1.98M, above open interest of 1”. The stock fell 0.87% in the next 10 minutes.
How far did LLY move after the headline?
From $1,360.48 just before the headline to $1,348.60 10 minutes later, a -0.87% move.
What else has moved LLY stock recently?
The two largest measured reactions before November 19, 2026: Nov 9, 2026, In a late-stage trial, Eli Lilly (LLY) says Zepbound, its obesity pill, significantly eased obstructive sleep apnea severity among patients with obesity. (+0.60% in 10 minutes); Nov 17, 2026, Eli Lilly (LLY) options: 136 Dec 18 '26 $1200 calls traded at the bid for $3.22M (-0.51% in 10 minutes).
Sources
-
LLY headline and measured reaction, Nov 19, 2026
— MoveSurge
The headline as it crossed, its timestamp, and the measured price reaction reported on this page.
Follow LLY live
The live feed pairs breaking headlines with measured price moves. Build a watchlist of stocks you own and choose whether matching news reaches your WhatsApp.
Open the live feed See portfolio WhatsApp alerts